← SynDRA
GLYCITEIN
SynDRA canonical compound SYN0009368 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Primary target(s) | TNF |
| Mechanism of action | Tumor necrosis factor release inhibitor |
All known targets
Mechanisms of action (all sources)
- Tumor necrosis factor release inhibitor
Drug classes
Cross-references
Synonyms
- 7,4'-Dihydroxy-6-methoxyisoflavone
- 7-hydroxy-3-(4-hydroxyphenyl)-6-methoxychromen-4-one
- CHEBI:34778
- RefChem:143895
- DTXCID80116451
- 6-methoxy-7,4'-dihydroxyisoflavone
- 7-hydroxy-3-(4-hydroxyphenyl)-6-methoxy-4H-chromen-4-one
- 4',7-Dihydroxy-6-methoxyisoflavone
- MFCD00016679
- Glycitein (Standard)
- UNII-92M5F28TVF
- Gycitein
- Glycetein (Standard)
- GLYCITEIN [USP-RS]
- SCHEMBL19720
- BIDD:ER0470
- Glycitein, analytical standard
- orb1300254
- orb3140037
- Glycitein, >=97% (HPLC)
- SCHEMBL29497281
- HY-N0016R
- HMS3886N16
- HY-N0016
- MSK40160
- AC-998
- BDBM50241530
- LMPK12050104
- s9107
- SBB065744
- AKOS015892762
- CCG-267294
- EBC-615358
- FG09960
- AS-71538
- DB-049688
- G4798
Look up GLYCITEIN in the interactive SynDRA portal →